Karthik Devarajan
Department of Cancer Research
Fox Chase Cancer Center
United States of America
Biography
Karthik Devarajan,Educational Background: PhD, Northern Illinois University, 2000. MSc, Tech, Birla Institute of Technology & Science, India, 1992. Industry Experience: Statistical Scientist, Cancer Bioinformatics, AstraZeneca R&D Boston, Waltham, MA, 2002-2005. Biostatistician, Bristol-Myers Squibb Pharmaceutical Research Institute, Bristol-Myers Squibb, Princeton, NJ, 1999-2002.
Research Interest
Biostatistics and Bioinformatics. Unsupervised dimension reduction.
Publications
-
Wang, M., Devarajan, K., Singal, A. G., Marrero, J. A., Dai, J., Feng, Z., ... & Lai, Y. (2016). The Doylestown algorithm: a test to improve the performance of AFP in the detection of hepatocellular carcinoma. Cancer Prevention Research, 9(2), 172-179.
-
Duong-Ly, K. C., Devarajan, K., Liang, S., Horiuchi, K. Y., Wang, Y., Ma, H., & Peterson, J. R. (2016). Kinase inhibitor profiling reveals unexpected opportunities to inhibit disease-associated mutant kinases. Cell reports, 14(4), 772-781.
-
Devarajan, K., & Cheung, V. C. (2016). A quasi-likelihood approach to nonnegative matrix factorization. Neural computation.
